A memory B cell response to Zika virus in dengue-infected patients produced antibodies that were poorly neutralizing in vitro and instead enhanced infection.
Epidemic may be peaking and could end within three years, scientists suggest; dengue antibodies enhance risk of Zika infection; considering new strategies for the control of mosquito-borne disease outbreaks